来自北克大麻登记处的不良事件报告的描述性分析
Yasmina Hachem1,2, Yola Moride3,4, Anne-Marie Castilloux5
1Medical Cannabis Program in Oncology, McGill University Health Center, Montréal, QC, Canada.
Drug safety
|November 23, 2023
概括
现实数据显示,医用大麻 (MC) 没有新的安全问题. 不良事件 (AEs) 根据药物的使用和大麻素含量而有所不同,因此需要进一步的风险管理,以获得有利的利益风险平衡.
科学领域:
- 药物监督 药物监督 药物监督
- 大麻素药物医学 大麻素药物医学
- 现实世界的证据 现实世界的证据
背景情况:
- 关于医用大麻 (MC) 的安全性,现实世界数据有限.
- 本研究描述了临床实践中MC启动后的不良事件 (AE).
研究的目的:
- 描述医用大麻 (MC) 的安全概况.
- 在现实环境中识别与MC使用相关的不良事件 (AE).
主要方法:
- 有2991名成年MC使用者的未来注册表 (北克大麻注册表).
- 在基线和随访期间收集的数据长达三年.
- 使用MedDRA首选术语编码的AE;进行了描述性分析.
主要成果:
- 3.6%的患者经历了中度或重度的副作用.
- 摄入MC最常见的副作用:头,恶心,昏昏欲睡,吐.
- 吸入MC最常见的副作用:头痛.
- 根据服用途径和大麻素含量 (THC,CBD,平衡) 的不同,AE概况有所不同.
结论:
- 与现有文献相比,没有发现新的安全问题.
- 根据MC的使用和大麻素成分,AE的概况会有很大差异.
- 需要对AE风险因素进行进一步的研究,以优化MC的利益风险.
相关概念视频
Types of Reports II: Incident or Occurrence Report
833
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
833
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacovigilance
857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857
Drug Control Governance: Regulatory Bodies and Their Impact
162
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
162
Quantitative Aspects of Drug-Receptor Interaction
1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K


